Request an Edit
Skip to main content
HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Utility Nav
CHOP.EDU
Careers
Ways to Give
Healthcare Professionals
International
Children's Hospital of Philadelphia
Menu
SEARCH
Main navigation
Find People
Our Research
Clinical Trials
About
Innovation
Faculty & Staff Resources
Make a Gift
Cardiotoxicity
1 - 1 of
1
Can Dexrazoxane Provide Cardioprotection During Treatment for Pediatric AML?
Published on
Jun 10, 2020
in
Cornerstone Blog
Researchers at CHOP found that dexrazoxane lowers risk for cardiotoxicity associated with chemotherapy in pediatric AML
